NCT06980753View on ClinicalTrials.gov

Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders

NANot yet recruitingINTERVENTIONAL

Enrollment

246

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions

Cushing SyndromePrimary AldosteronismAdrenal Insufficiency

Interventions

DEVICE

Participants will use the biossensor for 48 h

Trial Locations (1)

Unknown

University of São Paulo - General Hospital, São Paulo

All Listed Sponsors

collaborator

Swiss Federal Institute of Technology in Zurich (ETH Zurich)

UNKNOWN

collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Sao Paulo General Hospital

OTHER

NCT06980753 - Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders | Biotech Hunter | Biotech Hunter